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STUDIES OF HYPOXEMIC/ 
REOXYGENATION INJURY: 
WITH AORTIC CLAMPING 
XII. Delay of cardiac 
reoxygenation damage in 
the presence of cyanosis: A 
new concept of controlled 
cardiac reoxygenation 
Twenty-one immature piglets (<3 weeks old) underwent 30 minutes of aortic 
clamping with hypocalcemic glutamate/aspartate blood cardioplegia. Six pig- 
lets underwent hyperoxemic cardiopulmonary b pass and blood cardioplegia 
without preceding hypoxemia (control). Fifteen piglets became hypoxemic 
(oxygen tension about 25 mm Hg) for up to 2 hours by decreasing ventilator 
fraction of inspired oxygen to 6% to 7% before cardiopulmonary b pass. Of 
these, six piglets underwent 5 minutes of abrupt hyperoxemic uncontrolled 
reoxygenation bystarting cardiopulmonary b pass at oxygen tension of about 
400 mm Hg before they received oxygen tension of about 400 mm Hg blood 
cardioplegia. Nine others underwent controlled cardiac reoxygenation by 
starting cardiopulmonary bypass at ambient oxygen tension (about 25 mm Hg) 
followed 5 minutes later by 30 minutes of cardiopulmonary b pass at normox- 
emic oxygen tension (about 100 mm Hg) before raising oxygen tension to about 
400 mm Hg. Myocardial function after cardiopulmonary b pass was evaluated 
from end-systolic elastance by conductance catheter, oxidant damage was 
estimated by measuring transcoronary conjugated diene levels to detect lipid 
peroxidation, and antioxidant reserve capacity was determined by measuring 
malondialdehyde produced from myocardium incubated with the oxidant 
t-butylhydroperoxide. Hyperoxemic cardiopulmonary bypass and blood cardio- 
plegia preserved myocardial function and produced no oxidant damage in 
nonhypoxemic piglets. In contrast, uncontrolled reoxygenation at oxygen 
tension about 400 mm Hg, followed by blood cardioplegia, resulted in marked 
conjugated dienes production (42 _ 4* vs 3 --- 1) A233 nm/min/100 g during 
blood cardioplegic nduction, reduced antioxidant reserve capacity malondial- 
dehyde at 4 mmol/L t-butylhydroperoxide; 1342 - 59* vs 958 --- 50 nmol/g 
protein) and caused profound myocardial dysfunction; end-systolic elastance 
recovered only 21% +__ 2%* despite a blood cardioplegic regimen that was 
cardioprotective in nonhypoxemic piglets. Conversely, controlled cardiac 
reoxygenation reduced lipid peroxidation (conjugated dienes production was 
2 -+ 1"*), restored antioxidant reserve capacity (malondialdehyde at 4mmol/L 
t-butylhydroperoxide; 982- 88"*), and allowed near-complete (83 - 8%**) 
functional recovery. We conclude that reoxygenation f the hypoxemic mma- 
ture heart by initiating conventional hyperoxemic cardiopulmonary b pass 
causes oxidant damage characterized by lipid peroxidation, reduced antioxi- 
dant reserve capacity, and results in functional depression that nullifies the 
cardioprotective effects of blood cardioplegia. These changes can be reduced by 
starting cardiopulmonary b pass at the ambient oxygen tension of the hypox- 
emic subject and delaying subsequent reoxygenation u til blood cardioplegic 
induction by controlled cardiac reoxygenation (*p < 0.05 vs control; **p < 0.05 
vs uneontrol reoxygenation) and analysis of variance. (J THORAC CARDIOVASC 
SURG 1995;110:1265-73) 
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W ith increasing frequency, intraoperative cardiac repair of cyanotic heart defects is performed 
with cardiopulmonary b pass (CPB) in early infan- 
cy. ~ Postoperative low output syndrome in younger 
patients is more frequent han in adult patients and 
contributes to morbidity and mortality, 2 despite 
successful anatomic orrection of congenital defects. 
Clinically, CPB in hypoxemic infants is initiated 
usually at high oxygen tension (P%) (about 400 mm 
Hg) without consideration of the possible cytotoxic 
effects of reinstitution of molecular oxygen. We have 
speculated that reoxygenation of cyanotic myocar- 
dium at the onset of routine CPB causes unintended 
surgical reoxygenation i jury, which may add to 
subsequent intraoperative stress and compound 
myocardial dysfunction after CPB) 
Our hypothesis i based on reports that (1) cya- 
nosis reduces endogenous myocardial antioxidants 
(e.g., glutathione peroxidase 4) and (2) CPB per se 5 
and reoxygenation initiate potential oxidant damage 
via free radical generation. 6 The clinical relevance 
of findings is found in reports showing myocardial 
lipid peroxidation i preischemic myocardial biopsy 
samples from cyanotic children 7 and myocardial 
dysfunction in infants placed on extracorporeal 
membrane oxygenation) 
Reactive oxygen intermediates may play an inte- 
gral role in the pathogenesis of reperfusion and 
reoxygenation i juries. 9 We have shown also that 
reoxygenation damage may occur through the •- 
arginine-nitric oxide (.NO) pathway) Production of 
superoxide anion (02-) l° and subsequent tissue 
injury by reactive oxygen intermediates (hydroxyl 
ion, .OH and hydrogen peroxide, HzOa) are depen- 
dent on oxygen tension. Consequently, Po 2 at the 
onset of CPB may influence the occurrence of 
reoxygenation i jury, and we have documented the 
potential damaging effects of abrupt hyperoxemic 
reoxygenation without superimposed surgical isch- 
emia. 11 Furthermore, our previous tudies of global 
and regional ischemia 12-14 showed that modification 
of the conditions and composition of the reperfu- 
sion process limits or avoids reperfusion injury. 
This study tests whether these strategies can be 
applied to reoxygenation f hyperoxemic nfants by 
delaying the reoxygenation process until blood car- 
dioplegic arrest, where the composition and condi- 
tion of reoxygenation can be controlled. We evalu- 
ate the hypothesis that uncontrolled reoxygenation 
of hypoxemic immature hearts when starting CPB 
with conventional hyperoxemic Po 2 produces a 
reoxygenation injury that (1) nullifies the cardiopro- 
tective ffects of blood cardioplegia and (2) is avoid- 
able by starting CPB at the ambient Po 2 of the 
hypoxemic subject and delaying reoxygenation u til 
blood cardioplegic induction. We term this process 
controlled cardiac reoxygenation. 
Material and methods 
Experimental model. Twenty-one immature, 2- to 3- 
week-old Duroc-Yorkshire piglets (3 to 5 kg) were premed- 
icated with 0.5 mg/kg diazepam intramuscularly, anesthe- 
tized with 30 mg/kg pentobarbital intraperitoneally followed 
by 5 mg/kg intravenously each hour, and the lungs ventilated 
on a volume-limited respirator (Servo 900D, Siemens- 
Elema, Solna, Sweden) via a tracheostomy. All animals 
received humane care in compliance with the "Principles of 
Laboratory Animal Care" formulated by the National Soci- 
ety for Medical Research and the "Guide for the Care and 
Use of Laboratory Animals" prepared by the National 
Academy of Sciences, published by the National Institutes of 
Health (NIH Publication No. 86-23, revised 1985). 
An eight-electrode-equipped conductance catheter 
(Webster Laboratory, Baldwin Park, Calif.) was inserted 
through the left ventricular (LV) apex connected to a 
Sigma-5-DF Signal Conditioner Processor (Leycom 
Oegstgeest, The Netherlands). Myocardial function was 
evaluated by inscribing pressure-volume loops as described 
previously] 5 
A 16-gauge Teflon needle was placed in the proximal 
aorta to deliver cardioplegia..A heating pad was kept 
placed to keep the rectal temperature at 38 ° C. The 
extracorporeal circuit was primed with packed red cells 
from donor pigs, with calcium added to counteract itrate, 
hetastarch (Hespan, Dupont, Wilmington, Del.), and elec- 
trolyte solution (Plasmalyte, Baxter, Deerfield, Ill.). He- 
matocrit was kept between 25% to 30%, and a membrane 
oxygenator (16310 Membrane Oxygenator, Sarns, Ann 
Arbor, Mich.) was used in all studies. During CPB, mean 
aortic pressure was kept at about 50 mm Hg by adjusting 
systemic flow 100 to 120 ml/min/kg, and systemic temper- 
ature was kept at 37 ° C. The left ventricle was decom- 
pressed by inserting a vent through an apical stab wound. 
Measurements 
LV contractility. Left ventricular pressure and conduc- 
tance catheter signals were amplified and digitalized to 
inscribe LV pressure-volume loops. A series of pressure- 
volume loops under variable living conditions was gener- 
ated by transient occlusion of the inferior vena cava 
during 7 seconds of apnea under control conditions and 30 
minutes after the discontinuation of CPB. 16 The end- 
systolic pressure-volume r lationship was analyzed by 
user-interactive ideographics program (Spectrum ~7) on a 
386 MHz IBM-PC, and LV performance was described as 
a slope of end-systolic elastance (Ees) as described previ- 
ously. Postbypass LV contractility was assessed by percent 
recovery of prebypass control values (percent Ees). 
Myocardial "NO production..NO was determined in 
plasma by reconverting its oxidation end products, nitrite 
(NO2-) and nitrate (NO3-), to "NO and measuring 
chemiluminescence after NO reacts with ozone using the 
anitrogen oxide analyzer (Model 2108, DASIBI Environ- 
mental Corp., Glendale, Calif.). 18 Blood samples were 
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Fig. 1. Experimental model (see text for description). BCD, Blood cardioplegia; Re02, reoxygenation. 
taken from coronary perfusate (blood cardioplegia) and 
coronary effluent (coronary sinus blood) to assess the 
arteriovenous difference in .NO during induction of blood 
cardioplegia. Production of .NO was measured by the 
formula: .NO production = CBF × (V - A)/100 gm heart 
weight, where A and V are the respective concentrations 
of -NO measured in the aortic and coronary sinus blood 
during cardioplegic delivery when the cardioplegic solu- 
tion was administered at a fixed coronary blood flow rate 
by calibrated roller pump as described under control 
studies. 
Myocardial oxidant injury 
Conjugated iene production. During blood cardioplegic 
induction, blood samples were taken from the aorta 
(blood cardioplegia and coronary effluent), coronary sinus 
blood, and hydroxy conjugated dienes were determined by 
the method of Lefnesky and coworkers 19 as described 
previously. Myocardial conjugated iene production was 
calculated by the following formula and expressed as A233 
nm/min/kg: 
(CS - A) × CBF (ml/min)/heart weight (100 gm) 
where CS is coronary sinus plasma conjugated diene level, 
A is aortic blood cardioplegic perfusate, and CBF is 
coronary blood flow controlled by the flow rate of blood 
cardioplegic delivery (milliliters per minute). 
Antioxidant reserve capacity. In vitro lipid peroxidation 
was measured by the method of Godin and coworkers 2° to 
assess the antioxidant state or vulnerability to subsequent 
oxidant stress as described previously. 15 
Experimental groups 
Twenty-one piglets underwent 60 minutes of CPB and 
received blood cardioplegia during 30 minutes of aortic 
clamping. The aorta was clamped 5 minutes after CPB 
Table. Blood cardioplegia formulation 
Principle Constituent Final concentration 
Deliver oxygen Blood 
Maintain arrest KC1 
Buffer acidosis Tromethamine 
Avoid edema Glucose 
Restore substrate Glutamate 
Aspartate 
Glucose 
Limit calcium Citrate 
influx phosphate 
dextrose 
Hematocrit 20%-24% 
18-20 mEq/L (induction) 
10-12 mEq/L 
(reperfusion) 
pH 7.6-7.7 
Osmolarity 380-400 
mOsm 
13 mmol/L 
13 mmol/L 
>400 mg/dl 
(Ca+ +) 0.2-0.3 mmol/L 
was started, and all piglets underwent 25 additional min- 
utes on CPB after aortic unclamping. The method of 
management is shown in Fig. 1 for the control and 
experimental groups. Previous studies document the sta- 
bility of the model of the instrumented, ventilated piglet 
observed for 5 hours without CPB, hypoxemia, or reoxy- 
genation. 11, 21 
Blood cardioplegic protocol. All piglets received our 
standard clinical blood cardioplegic solution (hypocalce- 
mic, alkalotic, hyperosmolar, glutamate/aspartate-en- 
riched blood cardioplegia s shown in the Table. The 
blood cardioplegic protocol included (1) warm induction 
(KC1 20 mEq/L, 37 ° C, 20 ml/min/kg for 3 minutes), (2) 
cold replenishment (4° C, 10 ml/kg for 2 minutes), and (3) 
warm reperfusion (KC1 10 mEq/L, 37 ° C, 15 ml/min for 3 
minutes) for 3 minutes (just before aortic unclamping). 
5000- 
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Fig. 2..NO production during blood cardioplegia nduction in nonhypoxemic hearts (control) and during 
uncontrolled and controlled cardiac reoxygenation. 
Control studies 
Six nonhypoxemic piglets underwent 1hour of CPB at 
Po2 of about 400 mm Hg including 30 minutes of blood 
cardioplegia t Po2 of about 400 mm Hg to confirm the 
safety of the blood cardioplegic management method 
(control). 
Experimental studies 
Fifteen piglets were made hypoxemic by lowering frac- 
tion of inspired oxygen (Fioe) (6% to 7%) to result in an 
arterial oxygen tension (Pao2) of about 25 mm Hg for up 
to 120 minutes before CPB was started. CPB was begun 
before 120 minutes of hypoxemia if mean arterial 
pressure fell below 30 mm Hg or arterial pH could not 
be kept above 7.35 by bolus intravenous infusions of 
NaHCO 3. 
UNCONTROLLED REOXYGENATION. Six piglets underwent  
uncontrolled reoxygenation by starting CPB at the con- 
ventional hyperoxemic P02 of about 400 mm Hg (uncon- 
trolled reoxygenation). 
CONTROLLED CARDIAC REOXYGENATION. Nine piglets 
underwent controlled cardiac reoxygenation by starting 
CPB at the ambient Po2 of about 25 mm Hg occurring 
during hypoxemia. This was done by precirculating the 
extracorporeal circuit at Po 2 about 25 mm Hg by blending 
N2 and 0 2. Five minutes after the start of CPB, controlled 
cardiac reoxygenation was accomplished by raising the 
Po 2 of the CPB circuit to about 100 mm Hg immediately 
after clamping the aorta and by administering normox- 
emic (Po 2 about 100 mm Hg) blood cardioplegia. Arterial 
Po 2 was raised to about 400 mm Hg immediately after 
aortic unclamping. 
Systemic pressure was kept at about 50 mm Hg 
throughout CPB, and piglets were observed for 30 min- 
utes after CPB was discontinued; arterial blood gas and 
electrolytes were restored to normal before final func- 
tional measurements were made. 
The heart was arrested again with a cold (4 ° C) blood 
cardioplegic solution (KC1, 30 mEq/L) to stop metabolism 
after final functional measurements. A LV subendocardial 
myocardial specimen (about 200 mg) was obtained, frozen 
quickly in liquid nitrogen, and stored for subsequent 
biochemical nalyses. 
Statistics. Data were analyzed with the use of the 
StatView V2.0 program (Abacus Concepts Inc., Berkeley, 
Calif.) on a Macintosh Ilci computer (Apple, Inc., Cuper- 
tino, Calif.). Analysis of variance was used for inter- 
group comparison. Differences were considered signif- 
icant at the probability level of p < 0.05. Group data 
were expressed as mean plus or minus standard error of 
the mean. 
Results 
During hypoxemia, there was vasodilatation (the 
systemic vascular esistance index decreased by 32% 
_+ 15%) and the pulmonary vasoconstriction (pul- 
monary vascular esistance index increased 120% _+ 
21% of hypoxemic levels). The mean duration of 
hypoxemia veraged 73 -+ 15 minutes, and prema- 
ture institution of CPB was needed in 22 of 30 
piglets because of hemodynamic deterioration; a
similar proportion of each group required circula- 
tory support before 120 minutes of hypoxemia had 
elapsed. 
Myocardial .NO production. Hyperoxemic reoxy- 
genation (Po e > 400 mm Hg) on CPB was associ- 
ated with an l 1-fold increase in .NO production 
during cardioplegic induction compared with con- 
trol piglets given the same hyperoxemic blood car- 
dioplegic solution (Fig. 2). In contrast, this marked 
CD 
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Fig. 3. Myocardial conjugated diene production during blood cardioplegic nduction in nonhypoxemic 
hearts (control) and during uncontrolled and controlled cardiac reoxygenation. 
• NO production was reduced 94% by controlling 
cardiac reoxygenation by starting CPB at ambient 
hypoxemic Po 2 (about 25 mm Hg) and delaying 
reoxygenation u til normoxemic blood cardioplegia 
was given (Po 2 about 100 mm Hg) (Fig. 2). 
Myocardial conjugated diene production. Non- 
hypoxemic ontrol piglets (control group) showed 
negligible myocardial production of conjugated 
dienes during warm blood cardioplegic induction. 
Uncontrolled reoxygenation  CPB caused a 10- 
fold increase in conjugated iene production (Fig. 
3). Conversely, controlled cardiac reoxygenation 
limited conjugated iene production to levels seen 
in nonhypoxemic studies. 
Antioxidant reserve capacity. Uncontrolled reoxy- 
genation on CPB reduced antioxidant reserve capacity 
as malondialdehyde was increased significantly inmyo- 
cardial homogenates incubated with the oxidant t- 
butylhydroperoxide. Conversely, piglets managed by 
controlled cardiac reoxygenation retained antioxidant 
reserve capacity at levels observed in nonhypoxemic 
studies (Fig. 4). 
LV performance. Complete functional recovery 
followed 30 minutes of blood cardioplegic arrest in 
nonhypoxemic piglets (control) (Fig. 5). Conversely, 
uncontrolled reoxygenation  CPB at Po2 about 
400 mm Hg for 5 minutes before the start of the 
same blood cardioplegic protocol was associated 
with profound myocardial dysfunction, because Ees 
recovered only 21% ± 2%. Controlled cardiac 
reoxygenation bystarting CPB at the ambient (hy- 
poxemic) Po2 and delivering a normoxic blood car- 
dioplegic solution resulted in near-complete func- 
tional recovery, because Ees returned to 83% ± 3% 
of control values. 
Discussion 
This study documents the role of reoxygenation 
injury in the pathogenesis on postbypass cardiac 
dysfunction and addresses the importance of con- 
trolling Po2 at the onset of CPB as a cardioprotec- 
tive strategy for cyanotic infants. It confirms that (1) 
reoxygenation f hypoxemic mmature hearts at the 
onset of CPB causes oxygen-mediated damage char- 
acterized by lipid peroxidati0n, impairment of anti- 
oxidant reserve capacity, and functional depression, 
(2) this unintended injury nullifies the cardioprotec- 
tive effects of a blood cardioplegic protocol that is 
safe and nonhypoxemic piglets, and (3) the delete- 
rious effects of reoxygenation can be avoided by 
starting CPB at the ambient Po 2 of the hypoxemic 
subject and delaying reoxygenation u til blood car- 
dioplegic induction; controlled cardiac reoxygenation. 
Glutamate- and aspartate-enriched ypocalcemia, 
1270 Morita, lhnken, and Buckberg 
The Journal of Thoracic and 
Cardiovascular Surgery 
October 1995 
Antioxidant Reserve Capacity t 
MDA 
(nmol/g protein) 
1400 
1200 
1000 
200 
T 
Control 
• k P<O.05 vs. Control 
• k 'k  P<O.05 vs. Uncontrolled 
t @ 4 mmol/L t-Butyl hydroperoxide 
-T- 
\ \ \ \ \ \ \ \ \ ]  
Controlled Uncontrolled 
Reoxygenation 
Fig. 4. Antioxidant reserve capacity in cardiac homogenates after blood cardioplegia n nonhypoxemic 
hearts (control) and after uncontrolled and controlled cardiac reoxygenation. MDA, Malondialdehyde. 
alkalotic, hyperosmolar blood cardioplegia used in this 
study is employed routinely in high-risk adult pa- 
tients 22 and has been studied experimentally in energy- 
and substrate-depleted ischemic hearts. 23' 24 The same 
blood cardioplegic protocol that has been shown safe 
in non-~ypoxemic puppies was ineffective if applied 
after a period of reoxygenation CPB produced by 
initiating hyperoxemia n hypoxemic subjects. Con- 
versely, starting CPB at the ambient P02 and delaying 
reoxygenation a d initiating it more gradually by de- 
livering a normoxemic blood cardioplegic solution 
reduced cardiac damage substantially by avoiding lipid 
peroxidation, retaining antioxidant reserve capacity, 
and facilitating functional recovery. These findings are 
consistent with our previous tudies howing that con- 
trolled reperfusion after global 1;'13 and regional ~4 
ischemia limited reperfusion injury and that docu- 
mented oxygen-mediated damage as an important 
aspect of this processY These present data suggest 
that a similar salutary effect occurs in reoxygenation 
injury if the reintroduction f molecular 0 2 is delayed 
until the blood cardioplegic solution is administered; 
we term this process controlled cardiac reoxygenation. 
We speculate that several factors contribute to 
the benefits of blood cardioplegic reoxygenation 
including (1) potassium cardioplegic arrest, (2) 
modification of the blood cardioplegic content (i.e., 
alkalosis and hypocalcemia), (3) supplementation 
with glutamate and aspartate, and (4) lowering the 
P02 of blood cardioplegia nd have defined their 
individual benefits previously. 13' 26 We documented 
recently 3 that .NO, which is normally of physiologic 
benefit as endothelium-derived r laxation factor, 
contributes to reoxygenation i jury presumably 
through interacting with superoxide anion (02-) to 
form peroxynitrite (OONO-) and the highly toxic 
hydroxyl radical (.OH) as described by Beckman 
and colleagues. 27
Several components of the controlled reoxygen- 
ation strategy (e.g., lowering P02, 2s hypocalcemia, 29 
alkalosis, 3° and amino acid supplementation 31-34) 
can also limit .NO production and subsequent oxi- 
dant injury so that this new pathway of oxygen- 
mediated amage may be rendered less damaging by 
the controlled reoxygenation strategy. This may be 
especially true since sudden reoxygenation is asso- 
ciated with marked 0 2- and -NO production, z°' 28 
which may be limited by more gradual reoxygen- 
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Fig. 5. Recovery of contractile function, expressed as percent of control Ees after blood cardioplegia n
nonhypoxemic hearts (control), and after controlled and uncontrolled cardiac reoxygenation. 
ation (normoxemia rather than hyperoxemic ntro- 
duction of mo!ecular oxygen) and the use of blood 
cardioplegic solution containing components that 
reduce "NO synthase activity. Fig. 2 shows that "NO 
production was limited markedly by controlled car- 
diac reoxygenation. 
Antioxidant reserve capacity was measured to 
assess the Vulnerability to subsequent oxidant stress, 
because this measurement reflects the status of 
endogenous defenses (e.g., superoxide dismutase, 
glutathione). 2°Severe reduction of endogenous an- 
tioxidants persisted after reoxygenation on CPB, 
which suggests that reoxygenated myocardium ay 
become more susceptible to subsequent ischemic 
insults during cardiac repair and exhibit postbypass 
myocardia ! dysfunction. Conversely, controlled car- 
diac reoxygenation retained normal antioxidant re- 
serve capacity (perhaps accounting for the better 
tolerance to the period of aortic clamping imposed 
to simulate surgical conditions). 
Clinical implications. This study suggests that 
oxidant injury may occur if the conventional practice 
of starting hyperoxemic CPB in hypoxemic imma- 
ture hearts is followed and emphasizes the impor- 
tance of controlling the process of initial reoxygen- 
ation. Inherent weaknesses of the study include (1) 
failure to distinguish the effects of gradual reoxygen- 
ation without cardioplegic administration, (2) fail- 
ure to separate the roles of prebypass ischemia, 
which is common in the ventilator hypoxemia model 
and requires premature institution of bypass more 
than 70% of studies before 2 hours, and (3) the use 
of an acute rather than a chronic hypoxemic model. 
Our previous studies 21 document hat gradual 
reoxygenation (over a 1-hour period) does not limit 
reoxygenation damage, but the end point has always 
been hyperoxemia. We have shown also that reoxy- 
genation injury occurs even if hemodynamic deteri- 
oration and acidosis of ventilator hypoxemia re 
avoided by using a model of hypoxemia on bypass, is
Chronic cyanosis results in myocardial metabolic 
adaptations to maintain normal metabolism 35that 
do not occur in acute preparations. These adapta- 
tions notwithstanding, the results in these short- 
term studies are similar to those observed clinically; 
Teoh and coworkers 4 showed that chronic cyanosis 
depletes the myocardium of endogenous antioxi- 
dants (e.g., glutathione peroxidase, superoxide dis- 
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mutase). Del Nido and coworkers 7 reported evi- 
dence of lipid peroxidation of preischemic 
myocardial biopsy samples from cyanotic children 
placed on CPB, and myocardial dysfunction pro- 
gressing to myocardial stun occurs in cyanotic in- 
fants placed on extracorporeal membrane oxygen- 
ation without surgical ischemia, s 
We recognize that the profound myocardial dys- 
function measured in this study seems to conflict 
with the seemingly uneventful postoperative condi- 
tion after repair of cyanotic defects (e.g., pulmonary 
stenosis with ventricular septal defect). All piglets 
could maintain satisfactory hemodynamics without 
inotropic support, and we quantified contractile 
changes by sensitive indexes (Ees) that cannot be 
appreciated from the bedside. We suspect that reoxy- 
genation injury may further increase the vulnerability 
to subsequent ischemic/reperfusion damage when aor- 
tic clamping is needed for surgical repair and may 
contribute to postoperative cardiac dysfunction. Sub- 
sequent long-term studies are needed to determine if
reoxygenation i jury occurs in hearts adapted to hy- 
poxemia because the strategies used in this study are 
applicable readily during routine cardiac operations. 
Controlled cardiac reoxygenation may improve the 
outcome of cyanotic patients undergoing repair of 
congenital defects causing hypoxemia if our observa- 
tions are confirmed. 
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